Low serum zinc levels in patients undergoing coronary angiography correlate with immune activation and inflammation

Journal of Trace Elements in Medicine and Biology

Volumn 26, Issue 1, 2012, Pages 26-30

  Murr, Christian ^a   Pilz, Stefan ^b   Grammer, Tanja B ^c   Kleber, Marcus E ^c   Böhm, Bernhard O ^d   März, Winfried ^c,e   Fuchs, Dietmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c SYNLAB ACADEMY   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

C reactive protein; Coronary artery disease; Creatinine; Cystatin C; Neopterin; Zinc

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C; NEOPTERIN; ZINC;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INFLAMMATION; KIDNEY FUNCTION TEST; MALE; PRIORITY JOURNAL; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 84857720471     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2011.11.004     Document Type: Article

References (40)

1. Kruse-Jarres J.D. Pathogenesis and symptoms of zinc deficiency. Am Clin Lab 2001, 20:17-22.
2. Mocchegiani E., Malavolta M., Marcellini F., Pawelec G. Zinc, oxidative stress, genetic background and immunosenescence: implications for healthy ageing. Immun Ageing 2006, 3:6.
3. Prasad A.S. Zinc: mechanisms of host defense. J Nutr 2007, 137:1345-1349.
4. Beattie J.H., Kwun I.S. Is zinc deficiency a risk factor for atherosclerosis?. Br J Nutr 2004, 91:177-181.
5. Pilz S., Dobnig H., Winklhofer-Roob B.M., Renner W., Seelhorst U., Wellnitz B., et al. Low serum zinc concentrations predict mortality in patients referred to coronary angiography. Br J Nutr 2009, 101:1534-1540.
6. Pilz S., Maerz W., Weihrauch G., Sargsyan K., Almer G., Nauck M., et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2006, 364:251-255.
7. Murr C., Widner B., Wirleitner B., Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002, 3:175-187.
8. Melichar B., Zeimet A., Artner-Dworzak E., Schröcksnadel H., Marth C., Wachter H., et al. Association between increased urinary zinc and neopterin concentrations in women with gynaecological cancer. Tumor Diagn Ther 1993, 14:110-112.
9. Melichar B., Zangerle R., Artner-Dworzak E., Wachter H., Fuchs D. Are disturbances of zinc metabolism in human immunodeficiency virus type 1 (HIV-1) infection caused by immune activation?. Pteridines 1993, 4:195-199.
10. Melichar B., Aichberger C., Artner-Dworzak E., Weiss G., Margreiter R., Wachter H., et al. Immune activation and enhanced urinary zinc concentrations in allograft recipients. Presse Med 1994, 23:702-706.
11. Grammer T.B., Fuchs D., Boehm B.O., Winkelmann B.R., Maerz W. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 2009, 55:1135-1146.
12. Fuchs D., Avanzas P., Arroyo-Espliguero R., Jenny M., Consuegra Sanchez L., Kaski J.C. The role of neopterin in atherogenesis and cardiovascular risk stratification. Curr Med Chem 2009, 16:4644-4653.
13. Winkelmann B.R., März W., Boehm B.O., Zotz R., Hager J., Hellstern P., et al. Rationale and design of the LURIC study: a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001, 2:S1-S73.
14. Austen W.G., Edwards J.E., Frye R.L., Gensini G.G., Gott V.L., Griffith L.S., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975, 51(4 Suppl.):5-40.
15. Makino T., Saito M., Horiguchi D., Kina K. A highly sensitive colorimetric determination of serum zinc using water-soluble pyridylazo dye. Clin Chim Acta 1982, 120:127-135.
16. Johnsen O., Eliasson R. Evaluation of a commercially available kit for the colorimetric determination of zinc in human seminal plasma. Int J Androl 1987, 10:435-440.
17. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
18. Astor B.C., Levey A.S., Stevens L.A., Van Lente F., Selvin E., Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 2009, 20:2214-2222.
19. Giannoglou G.D., Konstantinou D.M., Kovatsi L., Chatzizisis Y.S., Mikhailidis D.P. Association of reduced zinc status with angiographically severe coronary atherosclerosis: a pilot study. Angiology 2010, 61:449-455.
20. Kazemi-Bajestani S.M., Ghayour-Mobarhan M., Ebrahimi M., Moohebati M., Esmaeili H.A., Parizadeh M.R., et al. Serum copper and zinc concentrations are lower in Iranian patients with angiographically defined coronary artery disease than in subjects with a normal angiogram. J Trace Elem Med Biol 2007, 21:22-28.
21. Minqin R., Watt F., Huat B.T., Halliwell B. Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. Free Radic Biol Med 2003, 34:746-752.
22. Hennig B., Meerarani P., Toborek M., McClain C.J. Antioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 1999, 18:152-158.
23. Alissa E.M., Bahjri S.M., Ahmed W.H., Al-Ama N., Ferns G.A. Trace element status in Saudi patients with established atherosclerosis. J Trace Elem Med Biol 2006, 20:105-114.
24. Martin-Moreno J.M., Gorgojo L., Riemersma R.A., Gomez-Aracena J., Kark J.D., Guillen J., et al. Myocardial infarction risk in relation to zinc concentration in toenails. Br J Nutr 2003, 89:673-678.
25. Kazi T.G., Afridi H.I., Kazi N., Jamali M.K., Arain M.B., Sarfraz R.A., et al. Distribution of zinc, copper and iron in biological samples of Pakistani myocardial infarction (1st, 2nd and 3rd heart attack) patients and controls. Clin Chim Acta 2008, 389:114-119.
26. Murr C., Winklhofer-Roob B.M., Schroecksnadel K., Maritschnegg M., Mangge H., Böhm B.O., et al. Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis 2009, 202:543-549.
27. Murr C., Talasz H., Artner-Dworzak E., Schroecksnadel K., Fiegl M., Fuchs D., et al. Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders. Clin Chem Lab Med 2007, 45:1224-1228.
28. Libby P., Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 1999, 100:1148-1150.
29. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983, 158:670-689.
30. Fuchs D., Baier-Bitterlich G., Wede I., Wachter H. Reactive oxygen and apoptosis. Oxidative stress and the molecular biology of antioxidant defenses 1997, 139-167. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. J. Scandalios (Ed.).
31. Murr C., Fuith L.-C., Widner B., Wirleitner B., Baier-Bitterlich G., Fuchs D. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?. Anticancer Res 1999, 19(3A):1721-1728.
32. Schroecksnadel S., Jenny M., Kurz K., Klein A., Ledochowski M., Uberall F., et al. LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 2010, 399:642-646.
33. Weiss G., Wachter H., Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol Today 1995, 16:495-500.
34. Arnaud C., Burger F., Steffens S., Veillard N.R., Nguyen T.H., Trono D., et al. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. Arterioscler Thromb Vasc Biol 2005, 25:1231-1236.
35. Schroeder J.J., Cousins R.J. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci U S A 1990, 87:3137-3141.
36. Klaiman A.P., Victery W., Kluger M.J., Vander A.J. Urinary excretion of zinc and iron following acute injection of dead bacteria in dog. Proc Soc Exp Biol Med 1981, 167:165-171.
37. Tidman M., Sjöström P., Jones I. A comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant 2008, 23:154-160.
38. van Acker B.A., Koomen G.C., Koopman M.G., de Waart D.R., Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992, 340:1326-1329.
39. Bray T.M., Bettger W.J. The physiological role of zinc as an antioxidant. Free Radic Biol Med 1990, 8:281-291.
40. Melichar B. Association between urinary zinc and neopterin excretion: a manifestation of the acute phase response in the kidney?. Pteridines 1993, 4:174-177.